ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,636 | -79.1% | 20,000 | 0.0% | 0.00% | – |
Q2 2023 | $12,600 | 0.0% | 20,000 | 0.0% | 0.00% | – |
Q1 2023 | $12,600 | -2.9% | 20,000 | 0.0% | 0.00% | – |
Q4 2022 | $12,982 | -61.8% | 20,000 | 0.0% | 0.00% | – |
Q3 2022 | $34,000 | +41.7% | 20,000 | 0.0% | 0.00% | – |
Q2 2022 | $24,000 | +84.6% | 20,000 | -2.9% | 0.00% | – |
Q1 2022 | $13,000 | -40.9% | 20,606 | 0.0% | 0.00% | – |
Q4 2021 | $22,000 | -40.5% | 20,606 | 0.0% | 0.00% | – |
Q3 2021 | $37,000 | -28.8% | 20,606 | +3.0% | 0.00% | – |
Q2 2021 | $52,000 | +2500.0% | 20,000 | +2122.2% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 900 | +42.0% | 0.00% | – |
Q2 2014 | $2,000 | 0.0% | 634 | 0.0% | 0.00% | – |
Q1 2014 | $2,000 | 0.0% | 634 | 0.0% | 0.00% | – |
Q4 2013 | $2,000 | – | 634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |